Provided by Tiger Trade Technology Pte. Ltd.

Edgewise Therapeutics, Inc.

31.94
+1.304.24%
Post-market: 31.940.00000.00%17:19 EDT
Volume:767.93K
Turnover:24.56M
Market Cap:3.43B
PE:-19.59
High:32.80
Open:31.00
Low:30.93
Close:30.64
52wk High:32.80
52wk Low:10.60
Shares:107.27M
Float Shares:60.85M
Volume Ratio:0.84
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6302
EPS(LYR):-1.6302
ROE:-34.19%
ROA:-23.02%
PB:6.56
PE(LYR):-19.59

Loading ...

Edgewise Therapeutics Inc : JP Morgan Raises Target Price to $34 From $33

THOMSON REUTERS
·
Nov 14, 2025

Director Jonathan C. Fox Reports Acquisition of Edgewise Therapeutics Inc. Common Shares

Reuters
·
Nov 14, 2025

Edgewise Therapeutics Files Initial Statement of Beneficial Ownership for CFO Michael Nofi

Reuters
·
Nov 14, 2025

Stock Track | Edgewise Therapeutics Plummets 5.12% Following Inducement Grants to New CFO

Stock Track
·
Nov 12, 2025

Stock Track | Edgewise Therapeutics Plummets 5.12% Following Inducement Grants to New CFO

Stock Track
·
Nov 12, 2025

Edgewise Therapeutics Grants Stock Options and RSUs to New CFO

Reuters
·
Nov 12, 2025

Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
Nov 12, 2025

Stock Track | Edgewise Therapeutics Soars 5.42% as New CFO Appointment Signals Potential Commercialization Plans

Stock Track
·
Nov 10, 2025

Press Release: Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers

Dow Jones
·
Nov 10, 2025

Edgewise Therapeutics Is Maintained at Outperform by Wedbush

Dow Jones
·
Nov 07, 2025

Edgewise Therapeutics to Participate in Guggenheim Healthcare Innovation Conference

Reuters
·
Nov 07, 2025

Wedbush Lowers Price Target on Edgewise Therapeutics to $32 From $35, Keeps Outperform Rating

MT Newswires Live
·
Nov 07, 2025

Edgewise Therapeutics (EWTX) Gets a Buy from RBC Capital

TIPRANKS
·
Nov 07, 2025

H.C. Wainwright Sticks to Their Buy Rating for Edgewise Therapeutics (EWTX)

TIPRANKS
·
Nov 07, 2025

Edgewise Therapeutics' Q3 Net Loss Widens, Beats Estimate; Shares Rise

MT Newswires Live
·
Nov 06, 2025

Edgewise Therapeutics Q3 EPS $(0.39) Beats $(0.40) Estimate

Benzinga
·
Nov 06, 2025

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q3 Net Loss $0.39 a Share, vs. FactSet Est of $0.42 Loss

MT Newswires Live
·
Nov 06, 2025

Edgewise Therapeutics reports Q3 EPS (39c), consensus (40c)

TIPRANKS
·
Nov 06, 2025

Edgewise Therapeutics Q3 net loss widens as R&D costs rise

Reuters
·
Nov 06, 2025

BRIEF-Edgewise Therapeutics Q3 Operating Expenses USD 46.858 Million

Reuters
·
Nov 06, 2025